Research Topics
| Elizabeth B LamontSummaryAffiliation: University of Chicago Country: USA Publications
| Collaborators
|
Detail Information
Publications
Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to"Elizabeth B Lamont
Section of General Internal Medicine, Department of Medicine, and the Cancer Research Center, University of Chicago, Chicago, IL, USA
JAMA 290:98-104. 2003..Using the vignette of a real patient with advanced cancer who far outlived her physician's prognostic estimate, we discuss clinical issues related to the science of prognosis in advanced cancer and the art of its disclosure...- Chemotherapy in the management of squamous-cell carcinoma of the head and neckE B Lamont
Section of Hematology Oncology, Cancer Research Center, University of Chicago, IL 60637, USA
Lancet Oncol 2:261-9. 2001.... - Physician factors in the timing of cancer patient referral to hospice palliative careElizabeth B Lamont
Sections of General Medicine and Hematology Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois, USA
Cancer 94:2733-7. 2002..In the current study, the authors attempted to determine whether the attributes of referring physicians were associated with the survival of terminally ill cancer patients in hospice... - Favorable cardiac risk among elderly breast carcinoma survivorsElizabeth B Lamont
Section of General Internal Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
Cancer 98:2-10. 2003..First, estrogens may be etiologic in the development of breast carcinoma and protective of CHD. Second, a common therapy for breast carcinoma (tamoxifen) may be associated with cardiac protection... - Low risk of hip fracture among elderly breast cancer survivorsElizabeth B Lamont
Department of Medicine, The University of Chicago, Chicago, IL, USA
Ann Epidemiol 13:698-703. 2003..Little prior work has evaluated whether women with breast cancer are at a decreased risk of osteoporotic fracture... - Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementiaSupriya K Gupta
Section of Hematology Oncology, University of Chicago, Chicago, Illinois 60637, USA
J Am Geriatr Soc 52:1681-7. 2004..To estimate patterns of colon cancer presentation, diagnosis, and treatment according to history of dementia using National Cancer Institute (NCI) Surveillance, Epidemiology, and End-Result (SEER) Medicare data... - Is patient travel distance associated with survival on phase II clinical trials in oncology?Elizabeth B Lamont
Department of Medicine and Cancer Research Center, The University of Chicago, Chicago, IL, USA
J Natl Cancer Inst 95:1370-5. 2003..We hypothesized that this phenomenon, often called "referral bias" or "distance bias," may also be evident in curative-intent cancer trials at specialized cancer centers... - Construct validity of medicare chemotherapy claims: the case of 5FUElizabeth B Lamont
Section of Hematology-Oncology, University of Chicago, Illinois 60637, USA
Med Care 40:201-11. 2002..Criterion validation studies with an external gold standard should be pursued to determine the sensitivity and specificity of chemotherapy codes in the Medicare NCH files... - Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancerTheodore J Iwashyna
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
J Clin Oncol 20:3992-8. 2002..In this study, we ask the following: (1) What is the hazard of death associated with adjuvant 5-FU in the general population of elderly stage III colon cancer patients? (2) Does the hazard vary with patient age?.. - Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiariesBlase N Polite
Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
Cancer 106:923-30. 2006..Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches... 
Understanding variation in primary prostate cancer treatment within the Veterans Health AdministrationVinod E Nambudiri
Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Urology 79:537-45. 2012..To examine the variation in prostate cancer treatment in the Veterans Health Administration (VHA)--a national, integrated delivery system. We also compared the care for older men in the VHA with that in fee-for-service Medicare...- Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)Elizabeth B Lamont
Massachusetts General Hospital Cancer Center and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
J Natl Cancer Inst 98:1335-8. 2006.... - Patient time costs associated with cancer careK Robin Yabroff
Health Services and Economics Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 99:14-23. 2007..In this study, we estimated patient time costs associated with cancer care in patients aged 65 years and older in the United States... 
NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?Elizabeth B Lamont
Massachusetts General Hospital Cancer Center, Boston, MA, USA
J Gen Intern Med 22:1166-71. 2007..We sought to estimate the effectiveness of NSAIDs in CRC prevention in the population of elderly Medicare beneficiaries, minimizing this selection bias...- Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participantsElizabeth B Lamont
Massachusetts General Hospital, Boston, Massachusetts, USA
Med Care 46:303-8. 2008..Because the elderly are underrepresented on clinical trials, physicians have few sources of information to estimate the risks (ie, toxicities) and benefits of chemotherapy administration to the elderly... - Cost of care for elderly cancer patients in the United StatesK Robin Yabroff
Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 100:630-41. 2008..We estimated net costs of care for elderly cancer patients in the United States for the 18 most prevalent cancers and for all other tumor sites combined... - Evaluation of trends in the cost of initial cancer treatmentJoan L Warren
Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 100:888-97. 2008..Despite reports of increases in the cost of cancer treatment, little is known about how costs of cancer treatment have changed over time and what services have contributed to the increases... - Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participantsElizabeth B Lamont
Department of Medicine and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA
J Natl Cancer Inst 97:1080-3. 2005..Administrative Medicare claims data appear to be a valid source of information for chemotherapy administered to elderly Medicare beneficiaries with cancer... - Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishmentsElectra D Paskett
Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA
Clin Cancer Res 12:3601s-5s. 2006..Cancer control research is growing and continues to gather momentum. This type of research is integral to providing quality care to patients and healthy populations...